Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
184B5
NM
Basal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
5896.067
uM
4.54790
8.20140
-0.9586 -1.0000 1.8632 0.4683
0.9969
1.4536
184A1
NM
Basal
GSK923295
CENPE
Kinesin
10002.001
uM
8.47170
11.6240
-0.9507 -1.0000 3.4729 0.2407
0.9439
0.5372
600MPE
HR+
Luminal
AS-252424
PI3K
PI3K
12224.165
uM
8.75170
136.14630
0.2719 -1.0000 0.4003 0.2034
0.8983
0.9714
184A1
NM
Basal
Temsirolimus
MTOR
MTOR
12509.168
uM
0.69862
4.34640
-0.9247 -1.0000 0.6010 0.6200
0.8824
1.3516
600MPE
HR+
Luminal
Vorinostat
HDAC
HDAC
5898.065
uM
45.55360
153.11150
-0.9868 -1.0000 0.9062 0.8120
0.9790
0.6845
AU565
HER2amp
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7793.016
uM
42.57250
65.16510
-0.8497 -1.0000 2.5806 0.2359
0.9519
1.1616
600MPE
HR+
Luminal
GSK1838705A
IGF1R
RTK
5899.098
uM
0.26223
1.66230
-0.8751 -1.0000 0.5949 0.6216
0.9891
1.1012
184B5
NM
Basal
Temsirolimus
MTOR
MTOR
12566.168
uM
31.79770
47.19180
-0.9110 -1.0000 2.7825 0.3358
0.8544
1.4366
184B5
NM
Basal
Topotecan
TOP1
TOP
9095.121
uM
0.07632
0.71426
-0.8323 -1.0000 0.4913 0.8207
0.9828
1.1992
184B5
NM
Basal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12566.169
uM
2.34370
11.34480
-0.7494 -1.0000 0.6966 0.3916
0.9813
1.6359
184A1
NM
Basal
Ibandronate
FDPS
12509.143
uM
155.22840
288.34070
-0.9140 -1.0000 1.7741 0.2785
0.9964
1.3392
600MPE
HR+
Luminal
AG1478
EGFR
ErbB
7791.016
uM
34.63250
70.58790
-0.6402 -1.0000 1.5428 0.2456
0.8929
0.8138
600MPE
HR+
Luminal
GSK1838705A
IGF1R
RTK
5899.07
uM
0.22856
0.81326
-0.9610 -1.0000 0.8656 0.6820
0.9966
0.8850
AU565
HER2amp
Luminal
L-779450
BRAF
MAPK
10880.149
uM
41.97630
133.38290
0.5726 -1.0000 0.9503 0.0531
0.9147
1.6289
600MPE
HR+
Luminal
Sigma A6730
AKT
AKT
12224.165
uM
6.5660
13.29760
-0.9371 -1.0000 1.5568 0.3611
0.9610
0.9714
AU565
HER2amp
Luminal
Everolimus
MTOR
MTOR
10880.156
uM
0.57383
7.51240
-0.8788 -1.0000 0.4272 0.4508
0.8269
1.5288
600MPE
HR+
Luminal
Oxamflatin
HDAC
HDAC
12224.147
uM
2.79220
7.38130
-0.9880 -1.0000 1.1301 0.3828
0.9872
0.8621
184B5
NM
Basal
Vorinostat
HDAC
HDAC
5896.065
uM
114.54920
884.06290
-0.8093 -1.0000 0.5376 0.5272
0.9847
1.4978
184A1
NM
Basal
IKK16
IKK
NFKB
5895.093
uM
1.01110
2.37210
-0.9564 -1.0000 1.2884 0.5085
0.9882
1.3259
AU565
HER2amp
Luminal
NU6102
CDK1/2
CDK
10880.147
uM
20.07910
29.68650
-0.8151 -1.0000 2.8097 0.1900
0.9822
1.5262
BT-474
HER2amp
Luminal
GSK1070916
AURK
AURK
9163.001
uM
2.92570
5.91270
-0.9570 -1.0000 1.5615 0.3033
0.9699
0.5227
184A1
NM
Basal
Imatinib
ABL/KIT/PDGFR
nRTK
5895.091
uM
16.09010
26.49230
-0.9899 -1.0000 2.2032 0.4630
0.9969
1.1729
600MPE
HR+
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9120.021
uM
16.89330
40.58020
-0.9570 -1.0000 1.2536 0.4435
0.9886
0.6486
BT-549
TNBC
Basal B
Erlotinib
EGFR
ErbB
5910.091
uM
110.23530
600.75210
0.6069 -1.0000 0.6479 0.0376
0.9246
3.3208
BT-549
TNBC
Basal B
CGC-11047
Polyamine analogue
10261.026
uM
64.76250
644.36690
-0.7483 -1.0000 0.4782 0.4717
0.8595
2.4866